psychedelics-investing Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026
psychedelics-investing Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
psychedelics-investing Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
psychedelics-investing Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
psychedelics-investing Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
psychedelics-investing Optimi Health Completes Largest Legal Natural Psilocybin Harvest in Canadian History
psychedelics-investing Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global
